Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for September 2007
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

BMS makes $430m biotech acquisition
Adnexus brings new biologic class to BMS' oncology programme..(more)

 News roundup from Datamonitor
Latest company and drug news..(more)

 AstraZeneca denies outsourcing plans
Company issues statement after Smith comment..(more)

 Brown outlines plans for NHS in a 'new era'
Deep-cleaning and more matrons on PM's list of hospital improvements..(more)

 European approval for GSK's cancer vaccine
Now Cervarix must race Sanofi's Gardasil for market lead..(more)

 Pfizer's Celsentri approved in Europe
Drug is first new oral HIV treatment in 10 years..(more)

 Takeda claims safety advantages for Actos
Study results cause switch from GSK's Avandia..(more)

 Clinton unveils plans for universal healthcare
But proposals draw criticism from all quarters..(more)

 Latest news from Datamonitor
Product roundup in cancer, MS and diabetes..(more)

 Pfizer closes Kent manufacturing base
Closure will result in loss of 420 jobs..(more)

 Fleishman-Hillard to assist UCB in its Cimzia launch
Drug expected to face tough competition in the anti-TNF market..(more)

 AstraZeneca looks to outflank cholesterol competitors
Company sets out on Crestor head-to-head against rival Vytorin..(more)

 BMS outsources safety monitoring to India
Deal reflects company's intention to invest in subcontinent and its overall global strategy ..(more)

 NICE approves MSD and Schering-Plough's Ezetrol
But NICE's cost restriction blocks combinination piill Inegy..(more)

 Novartis launches Cubicin for MRSA
Drug's lack of resistance problems and ease of adminisration makes its a promising contender in infection market..(more)

 Resolute wins first global account
London and New York offices join forces for Medicsight campaign ..(more)

 Latest news from Datamonitor
Product roundup in pain relief, diabetes, cancer, HIV and depression..(more)

 UK stem-cell research to benefit from hybrid embryos decision
Legislative restrictions in many EU countries give UK chance to take the lead..(more)

 Boehringer bids for oncology presence with lung cancer treatment
Company ready to compete in this rapidly growing and potentially lucrative market..(more)

 Generic challenger to Eprex approved
Biosimilar drug also poses threat to other anaemia blockbusters ..(more)

 European challenge to restrictions on Sutent prescribing
Tory MP argues 'postcode lottery' breaks EU law..(more)

 AZ opens clinical pharmacology unit in China
Move reflects company's growing influence and sales in China..(more)

 Sanofi manager wins Cranfield scholarship
£26,500 MBA scholarship aims to raise profile of women in management ..(more)

 NICE says yes to asthma treatment Xolair
But strict prescribing criteria will limit its use..(more)

 Merck Serono seeks first-line use for Erbitux
Approval could assure drug blockbuster status..(more)

 New Tsar of Tsars appointed to lead clinical engagement
Appointment underlines government's desire to heal rift between doctors and NHS leaders..(more)

 Pfizer and BMS to fight fat together
Companies to share costs on developing promising new anti-obesity compounds..(more)

 New Rebif formulation approved in Europe
Approval boosts Merck Serono's aim of retaining MS market leadership ..(more)

 GSK's orphan drug for leukaemia approved
Company takes a modest approach on pricing of Atriance..(more)

 Latest news from Datammonitor
Product roundup in cancer, inflammatory disease, cholesterol and leukaemia..(more)

 New blood pressure drug Rasilez approved in Europe
Novartis must convince doctors of superiority of its potential blockbuster..(more)

 Efficient NHS will stay out of debt, says Johnson
Health secretary predicts NHS will meet financial and service targets..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.